How does HIV affect my future? It doesn’t. Let’s Grow Old Together See what life with HIV looks like from diagnosis through grandkids with a little help from Walgreens. Explore Calvin’s HIV journey at Walgreens.com/LetsGrowOldTogether. ©2017 Walgreen Co. All rights reserved.
392078-191
1216
I am a devoted son, a singer, and an artist. And I am living with HIV.
Jamar has lived with HIV since 2006.
Get the facts. Get tested. Get involved. www.ActAgainstAIDS.org
YOU MATTER AND SO DOES YOUR HEALTH
That’s why starting and staying on HIV-1 treatment is so important.
What is DESCOVY ?
What are the other possible side effects of DESCOVY?
DESCOVY is a prescription medicine that is used together with other HIV-1 medicines to treat HIV-1 in people 12 years and older. DESCOVY is not for use to help reduce the risk of getting HIV-1 infection. DESCOVY combines 2 medicines into 1 pill taken once a day. Because DESCOVY by itself is not a complete treatment for HIV-1, it must be used together with other HIV-1 medicines.
Serious side effects of DESCOVY may also include:
®
DESCOVY does not cure HIV-1 infection or AIDS. To control HIV-1 infection and decrease HIV-related illnesses, you must keep taking DESCOVY. Ask your healthcare provider if you have questions about how to reduce the risk of passing HIV-1 to others. Always practice safer sex and use condoms to lower the chance of sexual contact with body fluids. Never reuse or share needles or other items that have body fluids on them.
IMPORTANT SAFETY INFORMATION What is the most important information I should know about DESCOVY? DESCOVY may cause serious side effects: •
•
•
•
Buildup of an acid in your blood (lactic acidosis), which is a serious medical emergency. Symptoms of lactic acidosis include feeling very weak or tired, unusual muscle pain, trouble breathing, stomach pain with nausea or vomiting, feeling cold (especially in your arms and legs), feeling dizzy or lightheaded, and/or a fast or irregular heartbeat. Serious liver problems. The liver may become large and fatty. Symptoms of liver problems include your skin or the white part of your eyes turning yellow (jaundice); dark “tea-colored” urine; light-colored bowel movements (stools); loss of appetite; nausea; and/or pain, aching, or tenderness on the right side of your stomach area. You may be more likely to get lactic acidosis or serious liver problems if you are female, very overweight, or have been taking DESCOVY for a long time. In some cases, lactic acidosis and serious liver problems have led to death. Call your healthcare provider right away if you have any symptoms of these conditions. Worsening of hepatitis B (HBV) infection. DESCOVY is not approved to treat HBV. If you have both HIV-1 and HBV and stop taking DESCOVY, your HBV may suddenly get worse. Do not stop taking DESCOVY without first talking to your healthcare provider, as they will need to monitor your health.
•
Changes in body fat, which can happen in people taking HIV-1 medicines.
•
Changes in your immune system. Your immune system may get stronger and begin to fight infections. Tell your healthcare provider if you have any new symptoms after you start taking DESCOVY.
•
Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. Your healthcare provider may tell you to stop taking DESCOVY if you develop new or worse kidney problems.
•
Bone problems, such as bone pain, softening, or thinning, which may lead to fractures. Your healthcare provider may do tests to check your bones.
The most common side effect of DESCOVY is nausea. Tell your healthcare provider if you have any side effects that bother you or don’t go away. What should I tell my healthcare provider before taking DESCOVY? •
All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney, bone, or liver problems, including hepatitis virus infection.
•
All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Other medicines may affect how DESCOVY works. Keep a list of all your medicines and show it to your healthcare provider and pharmacist. Ask your healthcare provider if it is safe to take DESCOVY with all of your other medicines.
•
If you are pregnant or plan to become pregnant. It is not known if DESCOVY can harm your unborn baby. Tell your healthcare provider if you become pregnant while taking DESCOVY.
•
If you are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed. HIV-1 can be passed to the baby in breast milk.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/ medwatch, or call 1-800-FDA-1088. Please see Important Facts about DESCOVY, including important warnings, on the following page.
Ask your healthcare provider if an HIV-1 treatment that contains DESCOVY® is right for you.
IMPORTANT FACTS (des-KOH-vee)
This is only a brief summary of important information about DESCOVY® and does not replace talking to your healthcare provider about your condition and your treatment.
MOST IMPORTANT INFORMATION ABOUT DESCOVY
POSSIBLE SIDE EFFECTS OF DESCOVY
DESCOVY may cause serious side effects, including:
DESCOVY can cause serious side effects, including:
• Buildup of lactic acid in your blood (lactic acidosis), which is a serious medical emergency that can lead to death. Call your healthcare provider right away if you have any of these symptoms: feeling very weak or tired, unusual muscle pain, trouble breathing, stomach pain with nausea or vomiting, feeling cold (especially in your arms and legs), feeling dizzy or lightheaded, and/or a fast or irregular heartbeat.
• Those in the “Most Important Information About DESCOVY” section. • Changes in body fat. • Changes in your immune system. • New or worse kidney problems, including kidney failure. • Bone problems.
• Severe liver problems, which in some cases can lead to death. Call your healthcare provider right away if you have any of these symptoms: your skin or the white part of your eyes turns yellow (jaundice); dark “tea-colored” urine; loss of appetite; light-colored bowel movements (stools); nausea; and/or pain, aching, or tenderness on the right side of your stomach area. • Worsening of hepatitis B (HBV) infection. DESCOVY is not approved to treat HBV. If you have both HIV-1 and HBV, your HBV may suddenly get worse if you stop taking DESCOVY. Do not stop taking DESCOVY without first talking to your healthcare provider, as they will need to check your health regularly for several months. You may be more likely to get lactic acidosis or severe liver problems if you are female, very overweight, or have been taking DESCOVY or a similar medicine for a long time.
ABOUT DESCOVY • DESCOVY is a prescription medicine that is used together with other HIV-1 medicines to treat HIV-1 in people 12 years of age and older. DESCOVY is not for use to help reduce the risk of getting HIV-1 infection. • DESCOVY does not cure HIV-1 or AIDS. Ask your healthcare provider about how to prevent passing HIV-1 to others.
The most common side effect of DESCOVY is nausea. These are not all the possible side effects of DESCOVY. Tell your healthcare provider right away if you have any new symptoms while taking DESCOVY. Your healthcare provider will need to do tests to monitor your health before and during treatment with DESCOVY.
BEFORE TAKING DESCOVY Tell your healthcare provider if you: • Have or had any kidney, bone, or liver problems, including hepatitis infection. • Have any other medical condition. • Are pregnant or plan to become pregnant. • Are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed if you have HIV-1 because of the risk of passing HIV-1 to your baby. Tell your healthcare provider about all the medicines you take: • Keep a list that includes all prescription and over-thecounter medicines, vitamins, and herbal supplements, and show it to your healthcare provider and pharmacist. • Ask your healthcare provider or pharmacist about medicines that should not be taken with DESCOVY.
GET MORE INFORMATION HOW TO TAKE DESCOVY • DESCOVY is a one pill, once a day HIV-1 medicine that is taken with other HIV-1 medicines. • Take DESCOVY with or without food.
• This is only a brief summary of important information about DESCOVY. Talk to your healthcare provider or pharmacist to learn more. • Go to DESCOVY.com or call 1-800-GILEAD-5 • If you need help paying for your medicine, visit DESCOVY.com for program information.
DESCOVY, the DESCOVY Logo, GILEAD, the GILEAD Logo, and LOVE WHAT’S INSIDE are trademarks of Gilead Sciences, Inc., or its related companies. All other marks referenced herein are the property of their respective owners. © 2016 Gilead Sciences, Inc. All rights reserved. GILC0265 10/16
• PREZCOBIX® is a prescription HIV-1 (Human Immunodeficiency Virus 1) medicine used with other antiretroviral medicines to treat HIV-1 infection in adults. HIV is the virus that causes AIDS (Acquired Immune Deficiency Syndrome). PREZCOBIX® contains the prescription medicines PREZISTA® (darunavir) and TYBOST® (cobicistat). • It is not known if PREZCOBIX® is safe and effective in children under 18 years of age. • When used with other antiretroviral medicines to treat HIV-1 infection, PREZCOBIX® may help:
dihydroergotamine (D.H.E.45®, Migranal®), ergotamine tartrate (Cafergot®, Ergomar®, Ergostat®, Medihaler®, Migergot®, Wigraine®, Wigrettes®), methylergonovine (Methergine®), lovastatin or a product that contains lovastatin (Altoprev®, Advicor®, Mevacor®), lurasidone (Latuda®), oral midazolam (Versed®), phenobarbital (Luminal®), phenytoin (Dilantin®, Dilantin-125®, Phenytek®), pimozide (Orap®), ranolazine (Ranexa®), rifampin (Rifadin®, Rifater®, Rifamate®, Rimactane®), sildenafil (Revatio®) when used for pulmonary arterial hypertension (PAH), simvastatin or a product that contains simvastatin (Simcor®, Vytorin®, Zocor®), St. John’s Wort (Hypericum perforatum) or a product that contains St. John’s Wort, or triazolam (Halcion®).
○ reduce the amount of HIV-1 in your blood. This is called “viral load.”
• Serious problems can happen if you take any of these medicines with PREZCOBIX.®
○ increase the number of CD4+ (T) cells in your blood that help fight off other infections.
What should I tell my healthcare provider before taking PREZCOBIX®?
• PREZCOBIX® is always taken in combination with other HIV medications for the treatment of HIV-1 infection in adults. PREZCOBIX® should be taken once daily with food. • PREZCOBIX® does not cure HIV-1 infection or AIDS, and you may still experience illnesses associated with HIV-1 infection. You must keep taking HIV-1 medicines to control HIV-1 infection and decrease HIV-related illnesses. • Ask your healthcare provider if you have any questions on how to prevent passing HIV to other people. • Please read the Important Safety Information below and talk to your healthcare provider to learn if PREZCOBIX® is right for you.
IMPORTANT SAFETY INFORMATION What is the most important information I should know about PREZCOBIX®? • PREZCOBIX® may cause liver problems. Some people taking PREZCOBIX® may develop liver problems which may be life-threatening. Your healthcare provider should do blood tests before and during your treatment with PREZCOBIX.® ○ Chronic hepatitis B or C infection may increase your chance of developing liver problems. Your healthcare provider should check your blood tests more often. ○ Signs and symptoms of liver problems include dark (tea-colored) urine, yellowing of your skin or whites of your eyes, pale-colored stools (bowel movements), nausea, vomiting, pain or tenderness on your right side below your ribs, or loss of appetite. Tell your healthcare provider if you develop any of these symptoms. • PREZCOBIX® may cause severe or life-threatening skin reactions or rash. Sometimes these skin reactions and skin rashes can become severe and require treatment in a hospital. Call your healthcare provider right away if you develop a rash. ○ Stop taking PREZCOBIX® and call your healthcare provider right away if you develop any skin changes with symptoms such as fever, tiredness, muscle or joint pain, blisters or skin lesions, mouth sores or ulcers, red or inflamed eyes like “pink eye” (conjunctivitis). • PREZCOBIX,® when taken with certain other medicines, can cause new or worse kidney problems, including kidney failure. Your healthcare provider should check your kidneys before you start and while you are taking PREZCOBIX.®
• About all health problems. Tell your healthcare provider if you have liver problems, including hepatitis B or hepatitis C, have kidney problems, are allergic to sulfa (sulfonamide), have diabetes, have hemophilia, or have any other medical condition, are pregnant, breastfeeding, or plan to become pregnant or breastfeed. Tell your healthcare provider if you become pregnant while taking PREZCOBIX.® • About all medicines you take. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some medicines interact with PREZCOBIX.® Keep a list of your medicines to show your healthcare provider and pharmacist. Do not start taking a new medicine without telling your healthcare provider. Your healthcare provider can tell you if it is safe to take PREZCOBIX® with other medicines. What are the possible side effects of PREZCOBIX®? • The most common side effects of darunavir, one of the medicines in PREZCOBIX,® include diarrhea, nausea, rash, headache, stomach area (abdominal) pain, and vomiting. • Other possible side effects include: ○ High blood sugar, diabetes or worsening diabetes, and increased bleeding in people with hemophilia have been reported in patients taking protease inhibitor medicines, including PREZCOBIX.® ○ Changes in body fat can happen in people who take HIV-1 medicines. The exact cause and long term health effects of these changes are not known. ○ Changes in your immune system (Immune Reconstitution Syndrome) can happen when you start taking HIV medicines. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. These are not all of the possible side effects of PREZCOBIX.® For more information, ask your healthcare provider. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Janssen Products, LP at 1-800-JANSSEN (1-800-526-7736). Please read accompanying Important Brief Summary for PREZCOBIX®.
Who should not take PREZCOBIX®? • Do not take PREZCOBIX® with any of the following medicines: alfuzosin (Uroxatral®), carbamazepine (Carbatrol®, Epitol®, Equetro®, Tegretol®, Tegretol-XR®, Teril®), cisapride (Propulsid®), colchicine (Colcrys®, Mitigare®, if you have liver or kidney problems), dronedarone (Multaq®), elbasvir and grazoprevir (Zepatier®),
Janssen Therapeutics, Division of Janssen Products, LP © Janssen Therapeutics, Division of Janssen Products, LP 2016 11/16 051975-161017
061037-161017
WHAT IS PREZCOBIX®?
ASK YOUR DOCTOR ABOUT DRUG RESISTANCE AND ONCE-DAILY* PREZCOBIX®
Wisdom inspired by real people
}
“I’M TAKING STEPS TO HELP MY TOMORROW.” When deciding on an HIV treatment, think long term. Everyone is at risk of developing drug resistance. Once-Daily* PREZCOBIX® has a high genetic barrier to resistance, which may help. PREZCOBIX® is taken in combination with other HIV medications for the treatment of HIV-1 infection in adults.
*
*
ONCE-DAILY
PREZCOBIX.com
“Learning is part of my journey. Asking questions helps me feel more confident.”
PREZCOBIX® (prez-koe-bix) (darunavir and cobicistat) tablets
What is PREZCOBIX® used for? PREZCOBIX® is a prescription HIV-1 (Human Immunodeficiency Virus 1) medicine used with other antiretroviral medicines to treat HIV-1 infection in adults. HIV is the virus that causes AIDS (Acquired Immune Deficiency Syndrome). PREZCOBIX® contains prescription medicines PREZISTA® (darunavir) and TYBOST® (cobicistat). PREZCOBIX® does not cure HIV-1 infection or AIDS. You must keep taking HIV-1 medicines to control HIV-1 infection and decrease HIV-related illnesses. What are the most serious warnings about PREZCOBIX®? • PREZCOBIX® may cause liver problems which may be life-threatening. Tell your healthcare provider right away if you have any symptoms such as: • Vomiting • Dark (tea-colored) urine • Pain or tenderness on your right side below your ribs • Yellowing of your skin or the whites of your eyes • Loss of appetite • Pale-colored stools (bowel movements) • Nausea • PREZCOBIX® may cause severe or life-threatening skin reactions or rashes. Stop taking PREZCOBIX® and call your healthcare provider right away if you develop any skin changes with symptoms below: • Blisters or skin lesions • Fever • Mouth sores or ulcers • Tiredness • Red or inflamed eyes, like “pink eye” (conjunctivitis) • Muscle or joint pain • PREZCOBIX,® when taken with some other medications, can cause new or worse kidney problems, including kidney failure. What do I need to tell my healthcare provider? Tell your healthcare provider if you: • Have liver problems, including hepatitis B or hepatitis C • Have kidney problems • Are allergic to sulfa (sulfonamide) • Have diabetes • Have hemophilia • Have any other medical condition
• Are pregnant or plan to become pregnant. (It is not known if PREZCOBIX® will harm your unborn baby. Tell your healthcare provider if you become pregnant while taking PREZCOBIX.®) • Are breastfeeding or plan to breastfeed. Do not breastfeed if you take PREZCOBIX® because it is unknown if PREZCOBIX® can pass into your breast milk. You should not breastfeed if you have HIV-1 because of the risk of passing HIV to your baby.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Some medications may prevent PREZCOBIX® from working or cause increased side effects. Do not start taking a new medicine without telling your healthcare provider. Who should not take PREZCOBIX®? • Do not take PREZCOBIX® with any of the following medicines: alfuzosin (Uroxatral®), carbamazepine (Carbatrol®, Epitol®, Equetro®, Tegretol®, Tegretol-XR®, Teril®), cisapride (Propulsid®), colchicine (Colcrys®, Mitigare®, if you have liver or kidney problems), dronedarone (Multaq®), elbasvir and grazoprevir (Zepatier®), dihydroergotamine (D.H.E.45®, Migranal®), ergotamine tartrate (Cafergot ®, Ergomar ®, Ergostat ®, Medihaler,® Migergot,® Wigraine®, Wigrettes®), methylergonovine (Methergine®), lovastatin or a product that contains lovastatin (Altoprev,® Advicor,® Mevacor ®), lurasidone (Latuda®), oral midazolam (Versed®), phenobarbital (Luminal®), phenytoin (Dilantin®, Dilantin-125®, Phenytek®), pimozide (Orap®), ranolazine (Ranexa®), rifampin (Rifadin®, Rifater ®, Rifamate®, Rimactane®), sildenafil (Revatio®) when used for pulmonary arterial hypertension (PAH), simvastatin or a product that contains simvastatin (Simcor,® Vytorin®, Zocor ®), St. John’s Wort (Hypericum perforatum) or a product that contains St. John’s Wort, or triazolam (Halcion®). • Serious problems can happen if you take any of these medicines with PREZCOBIX.® What are the possible side effects of PREZCOBIX®? PREZCOBIX® may cause serious side effects including: • Diabetes and high blood sugar • Changes in body fat can happen in people taking HIV-1 medications • Immune system changes (Immune Reconstitution Syndrome) can happen in people who start HIV-1 medications • Increased bleeding can occur in people with hemophilia who are taking PREZCOBIX.® The most common side effects are: • Diarrhea • Headache • Nausea • Stomach area (abdominal) pain • Rash • Vomiting These are not all of the possible side effects of PREZCOBIX®. For more information, ask your healthcare provider. What should I know about this Brief Summary? This information is not complete. To get more information: • Talk to your healthcare provider or pharmacist • Visit www.PREZCOBIX.com to read over the FDA-approved product labeling and patient information • Call to report side effects either to the FDA at 1-800-FDA-1088 or to Janssen Products, LP at 1-800-JANSSEN (1-800-526-7736). © Janssen Therapeutics, Division of Janssen Products, LP 2016 10/16 054195-160602
WHAT IS ODEFSEY®?
What are the other possible side effects of ODEFSEY?
ODEFSEY is a 1-pill, once-a-day prescription medicine used to treat HIV-1 in people 12 years and older. It can either be used in people who are starting HIV-1 treatment, have never taken HIV-1 medicines before, and have an amount of HIV-1 in their blood (“viral load”) that is no more than 100,000 copies/mL; or in people who are replacing their current HIV-1 medicines and whose healthcare provider determines they meet certain requirements. These include having an undetectable viral load (less than 50 copies/mL) for 6 months or more on their current HIV-1 treatment. ODEFSEY combines 3 medicines into 1 pill taken once a day with a meal. ODEFSEY is a complete HIV-1 treatment and should not be used with other HIV-1 medicines.
Serious side effects of ODEFSEY may also include: • Severe skin rash and allergic reactions. Skin rash is a common side effect of ODEFSEY. Call your healthcare provider right away if you get a rash, as some rashes and allergic reactions may need to be treated in a hospital. Stop taking ODEFSEY and get medical help right away if you get a rash with any of the following symptoms: fever, skin blisters, mouth sores, redness or swelling of the eyes (conjunctivitis), swelling of the face, lips, mouth, or throat, trouble breathing or swallowing, pain on the right side of the stomach (abdominal) area, and/or dark “tea-colored” urine. • Depression or mood changes. Tell your healthcare provider right away if you: feel sad or hopeless, feel anxious or restless, have thoughts of hurting yourself (suicide) or have tried to hurt yourself. • Changes in liver enzymes. People who have had hepatitis B or C or who have certain liver enzyme changes may have a higher risk for new or worse liver problems while taking ODEFSEY. Liver problems can also happen in people who have not had liver disease. Your healthcare provider may do tests to check your liver enzymes before and during treatment with ODEFSEY. • Changes in body fat, which can happen in people taking HIV-1 medicines. • Changes in your immune system. Your immune system may get stronger and begin to fight infections. Tell your healthcare provider if you have any new symptoms after you start taking ODEFSEY. • Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. Your healthcare provider may tell you to stop taking ODEFSEY if you develop new or worse kidney problems. • Bone problems, such as bone pain, softening, or thinning, which may lead to fractures. Your healthcare provider may do tests to check your bones.
ODEFSEY does not cure HIV-1 infection or AIDS. To control HIV-1 infection and decrease HIV-related illnesses, you must keep taking ODEFSEY. Ask your healthcare provider if you have questions about how to reduce the risk of passing HIV-1 to others. Always practice safer sex and use condoms to lower the chance of sexual contact with body fluids. Never reuse or share needles or other items that have body fluids on them.
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about ODEFSEY? ODEFSEY may cause serious side effects: • Buildup of an acid in your blood (lactic acidosis), which is a serious medical emergency. Symptoms of lactic acidosis include feeling very weak or tired, unusual muscle pain, trouble breathing, stomach pain with nausea or vomiting, feeling cold (especially in your arms and legs), feeling dizzy or lightheaded, and/or a fast or irregular heartbeat. • Serious liver problems. The liver may become large and fatty. Symptoms of liver problems include your skin or the white part of your eyes turning yellow (jaundice); dark “tea-colored” urine; loss of appetite; light-colored bowel movements (stools); nausea; and/or pain, aching, or tenderness on the right side of your stomach area. • You may be more likely to get lactic acidosis or serious liver problems if you are female, very overweight, or have been taking ODEFSEY or a similar medicine for a long time. In some cases, lactic acidosis and serious liver problems have led to death. Call your healthcare provider right away if you have any symptoms of these conditions.
• Worsening of hepatitis B virus (HBV) infection. ODEFSEY
is not approved to treat HBV. If you have both HIV-1 and HBV and stop taking ODEFSEY, your HBV may suddenly get worse. Do not stop taking ODEFSEY without first talking to your healthcare provider, as they will need to monitor your health.
Who should not take ODEFSEY? Do not take ODEFSEY if you take: • Certain prescription medicines for other conditions. It is important to ask your healthcare provider or pharmacist about medicines that should not be taken with ODEFSEY. Do not start a new medicine without telling your healthcare provider. • The herbal supplement St. John’s wort. • Any other medicines to treat HIV-1 infection.
The most common side effects of rilpivirine, one of the medicines in ODEFSEY, are depression, trouble sleeping (insomnia), and headache. The most common side effect of emtricitabine and tenofovir alafenamide, two of the medicines in ODEFSEY, is nausea. Tell your healthcare provider if you have any side effects that bother you or do not go away.
What should I tell my healthcare provider before taking ODEFSEY? • All your health problems. Be sure to tell your healthcare
provider if you have or have had any kidney, bone, mental health (depression or suicidal thoughts), or liver problems, including hepatitis virus infection. • All the medicines you take, including prescription and overthe-counter medicines, vitamins, and herbal supplements. Other medicines may affect how ODEFSEY works. Keep a list of all your medicines and show it to your healthcare provider and pharmacist. Ask your healthcare provider if it is safe to take ODEFSEY with all of your other medicines. • If you are pregnant or plan to become pregnant. It is not known if ODEFSEY can harm your unborn baby. Tell your healthcare provider if you become pregnant while taking ODEFSEY. • If you are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed. HIV-1 can be passed to the baby in breast milk.
Ask your healthcare provider if ODEFSEY is right for you, and visit ODEFSEY.com to learn more. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see Important Facts about ODEFSEY including important warnings on the following page.
ODEFSEY does not cure HIV-1 or AIDS.
SHOW YOUR
RADIANCE
ODEFSEY is a complete, 1-pill, once-a-day HIV-1 treatment for people 12 years and older who are either new to treatment and have less than 100,000 copies/mL of virus in their blood or people whose healthcare provider determines they can replace their current HIV-1 medicines with ODEFSEY.
IMPORTANT FACTS This is only a brief summary of important information about ODEFSEY® and does not replace talking to your healthcare provider about your condition and your treatment.
(oh-DEF-see) MOST IMPORTANT INFORMATION ABOUT ODEFSEY
POSSIBLE SIDE EFFECTS OF ODEFSEY
ODEFSEY may cause serious side effects, including:
ODEFSEY can cause serious side effects, including:
•
•
•
Buildup of lactic acid in your blood (lactic acidosis), which is a serious medical emergency that can lead to death. Call your healthcare provider right away if you have any of these symptoms: feeling very weak or tired, unusual muscle pain, trouble breathing, stomach pain with nausea or vomiting, feeling cold (especially in your arms and legs), feeling dizzy or lightheaded, and/or a fast or irregular heartbeat.
•
Severe liver problems, which in some cases can lead to death. Call your healthcare provider right away if you have any of these symptoms: your skin or the white part of your eyes turns yellow (jaundice); dark “tea-colored” urine; loss of appetite; light-colored bowel movements (stools); nausea; and/ or pain, aching, or tenderness on the right side of your stomach area.
•
Worsening of hepatitis B (HBV) infection. ODEFSEY is not approved to treat HBV. If you have both HIV-1 and HBV, your HBV may suddenly get worse if you stop taking ODEFSEY. Do not stop taking ODEFSEY without first talking to your healthcare provider, as they will need to check your health regularly for several months.
You may be more likely to get lactic acidosis or severe liver problems if you are female, very overweight, or have been taking ODEFSEY or a similar medicine for a long time.
• • • •
• •
Those in the “Most Important Information About ODEFSEY” section. Severe skin rash and allergic reactions. Depression or mood changes. Changes in liver enzymes. Changes in body fat. Changes in your immune system. New or worse kidney problems, including kidney failure. Bone problems.
The most common side effects of rilpivirine, one of the medicines in ODEFSEY, are depression, trouble sleeping (insomnia), and headache. The most common side effect of emtricitabine and tenofovir alafenamide, two of the medicines in ODEFSEY, is nausea. These are not all the possible side effects of ODEFSEY. Tell your healthcare provider right away if you have any new symptoms while taking ODEFSEY. Your healthcare provider will need to do tests to monitor your health before and during treatment with ODEFSEY.
BEFORE TAKING ODEFSEY
ABOUT ODEFSEY •
ODEFSEY is a prescription medicine used to treat HIV-1 in people 12 years of age and older who have never taken HIV-1 medicines before and who have an amount of HIV-1 in their blood (“viral load”) that is no more than 100,000 copies/mL. ODEFSEY can also be used to replace current HIV-1 medicines for some people who have an undetectable viral load (less than 50 copies/ mL), have been on the same HIV-1 medicines for at least 6 months, have never failed HIV-1 treatment, and whose healthcare provider determines that they meet certain other requirements.
•
ODEFSEY does not cure HIV-1 or AIDS. Ask your healthcare provider about how to prevent passing HIV-1 to others.
Do NOT take ODEFSEY if you: • Take a medicine that contains: carbamazepine (Carbatrol®, Epitol®, Equetro®, Tegretol®, Tegretol-XR®, Teril®), dexamethasone (Ozurdex®, Maxidex®, Decadron®, Baycadron™), dexlansoprazole (Dexilant®), esomeprazole (Nexium®, Vimovo®), lansoprazole (Prevacid®), omeprazole (Prilosec®, Zegerid®), oxcarbazepine (Trileptal®), pantoprazole sodium (Protonix®), phenobarbital (Luminal®), phenytoin (Dilantin®, Dilantin-125®, Phenytek®), rabeprazole (Aciphex®), rifampin (Rifadin®, Rifamate®, Rifater®, Rimactane®), or rifapentine (Priftin®). •
Take the herbal supplement St. John’s wort.
•
Take any other HIV-1 medicines at the same time.
Tell your healthcare provider if you: • Have or have had any kidney, bone, mental health (depression or suicidal thoughts), or liver problems, including hepatitis infection. • Have any other medical condition. • Are pregnant or plan to become pregnant. • Are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed if you have HIV-1 because of the risk of passing HIV-1 to your baby. Tell your healthcare provider about all the medicines you take: • Keep a list that includes all prescription and over-the-counter medicines, vitamins, and herbal supplements, and show it to your healthcare provider and pharmacist. • Ask your healthcare provider or pharmacist about medicines that should not be taken with ODEFSEY.
HOW TO TAKE ODEFSEY • •
ODEFSEY is a complete 1-pill, once-a-day HIV-1 medicine. Take ODEFSEY with a meal.
GET MORE INFORMATION •
• •
This is only a brief summary of important information about ODEFSEY. Talk to your healthcare provider or pharmacist to learn more. Go to ODEFSEY.com or call 1-800-GILEAD-5 If you need help paying for your medicine, visit ODEFSEY.com for program information.
ODEFSEY, the ODEFSEY Logo, GILEAD, and the GILEAD Logo are trademarks of Gilead Sciences, Inc., or its related companies. All other marks referenced herein are the property of their respective owners. Version date: March 2016 © 2016 Gilead Sciences, Inc. All rights reserved. ODEC0026 06/16
What is TRUVADA for PrEP (Pre-exposure Prophylaxis)?
uYou may be more likely to get lactic acidosis or serious liver problems
TRUVADA is a prescription medicine that can be used for PrEP to help reduce the risk of getting HIV-1 infection when used together with safer sex practices. This use is only for adults who are at high risk of getting HIV-1 through sex. This includes HIV-negative men who have sex with men and who are at high risk of getting infected with HIV-1 through sex, and malefemale sex partners when one partner has HIV-1 infection and the other does not. Ask your healthcare provider if you have questions about how to prevent getting HIV-1. Always practice safer sex and use condoms to lower the chance of sexual contact with body fluids. Never reuse or share needles or other items that have body fluids on them.
Who should not take TRUVADA for PrEP?
IMPORTANT SAFETY INFORMATION What is the most important information I should know about TRUVADA for PrEP?
Before taking TRUVADA for PrEP to reduce your risk of getting HIV-1 infection: uYou must be HIV-negative. You must get tested to make sure that you do not already have HIV-1 infection. Do not take TRUVADA for PrEP to reduce the risk of getting HIV-1 unless you are confirmed to be HIV-negative. uMany HIV-1 tests can miss HIV-1 infection in a person who has recently become infected. If you have flu-like symptoms, you could have recently become infected with HIV-1. Tell your healthcare provider if you had a flu-like illness within the last month before starting TRUVADA for PrEP or at any time while taking TRUVADA for PrEP. Symptoms of new HIV-1 infection include tiredness, fever, joint or muscle aches, headache, sore throat, vomiting, diarrhea, rash, night sweats, and/or enlarged lymph nodes in the neck or groin. While taking TRUVADA for PrEP to reduce your risk of getting HIV-1 infection: uYou must continue using safer sex practices. Just taking TRUVADA for PrEP may not keep you from getting HIV-1. uYou must stay HIV-negative to keep taking TRUVADA for PrEP. uTo further help reduce your risk of getting HIV-1: • Know your HIV-1 status and the HIV-1 status of your partners. • Get tested for HIV-1 at least every 3 months or when your healthcare provider tells you. • Get tested for other sexually transmitted infections. Other infections make it easier for HIV-1 to infect you. • Get information and support to help reduce risky sexual behavior. • Have fewer sex partners. • Do not miss any doses of TRUVADA. Missing doses may increase your risk of getting HIV-1 infection. • If you think you were exposed to HIV-1, tell your healthcare provider right away. uIf you do become HIV-1 positive, you need more medicine than TRUVADA alone to treat HIV-1. TRUVADA by itself is not a complete treatment for HIV-1. If you have HIV-1 and take only TRUVADA, your HIV-1 may become harder to treat over time. TRUVADA can cause serious side effects: uToo much lactic acid in your blood (lactic acidosis), which is a serious medical emergency. Symptoms of lactic acidosis include weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, nausea, vomiting, stomach-area pain, cold or blue hands and feet, feeling dizzy or lightheaded, and/or fast or abnormal heartbeats. uSerious liver problems. Your liver may become large and tender, and you may develop fat in your liver. Symptoms of liver problems include your skin or the white part of your eyes turns yellow, dark “tea-colored” urine, lightcolored stools, loss of appetite for several days or longer, nausea, and/or stomach-area pain.
if you are female, very overweight (obese), or have been taking TRUVADA for a long time. In some cases, these serious conditions have led to death. Call your healthcare provider right away if you have any symptoms of these conditions. uWorsening of hepatitis B (HBV) infection. If you also have HBV and take TRUVADA, your hepatitis may become worse if you stop taking TRUVADA. Do not stop taking TRUVADA without first talking to your healthcare provider. If your healthcare provider tells you to stop taking TRUVADA, they will need to watch you closely for several months to monitor your health. TRUVADA is not approved for the treatment of HBV. Do not take TRUVADA for PrEP if you already have HIV-1 infection or if you do not know your HIV-1 status. If you are HIV-1 positive, you need to take other medicines with TRUVADA to treat HIV-1. TRUVADA by itself is not a complete treatment for HIV-1. If you have HIV-1 and take only TRUVADA, your HIV-1 may become harder to treat over time. Do not take TRUVADA for PrEP if you also take lamivudine (Epivir-HBV) or adefovir (HEPSERA).
What are the other possible side effects of TRUVADA for PrEP?
Serious side effects of TRUVADA may also include: uKidney problems, including kidney failure. Your healthcare provider may do blood tests to check your kidneys before and during treatment with TRUVADA for PrEP. If you develop kidney problems, your healthcare provider may tell you to stop taking TRUVADA for PrEP. uBone problems, including bone pain or bones getting soft or thin, may lead to fractures. Your healthcare provider may do tests to check your bones. uChanges in body fat, which can happen in people taking TRUVADA or medicines like TRUVADA. Common side effects in people taking TRUVADA for PrEP are stomacharea (abdomen) pain, headache, and decreased weight. Tell your healthcare provider if you have any side effects that bother you or do not go away.
What should I tell my healthcare provider before taking TRUVADA for PrEP?
uAll your health problems. Be sure to tell your healthcare provider if you
have or have had any kidney, bone, or liver problems, including hepatitis virus infection. uIf you are pregnant or plan to become pregnant. It is not known if TRUVADA can harm your unborn baby. If you become pregnant while taking TRUVADA for PrEP, talk to your healthcare provider to decide if you should keep taking TRUVADA for PrEP. Pregnancy Registry: A pregnancy registry collects information about your health and the health of your baby. There is a pregnancy registry for women who take medicines to prevent HIV-1 during pregnancy. For more information about the registry and how it works, talk to your healthcare provider. uIf you are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed. The medicines in TRUVADA can pass to your baby in breast milk. If you become HIV-1 positive, HIV-1 can be passed to the baby in breast milk. uAll the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TRUVADA may interact with other medicines. Keep a list of all your medicines and show it to your healthcare provider and pharmacist when you get a new medicine. uIf you take certain other medicines with TRUVADA for PrEP, your healthcare provider may need to check you more often or change your dose. These medicines include ledipasvir with sofosbuvir (HARVONI). You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch, or call 1-800-FDA-1088.
Please see Important Facts about TRUVADA for PrEP including important warnings on the following page.
Have you heard about
TRUVADA for PrEP ? TM
The once-daily prescription medicine that can help reduce the risk of getting HIV-1 when used with safer sex practices. • TRUVADA for PrEP is only for adults who are at high risk of getting HIV through sex. • You must be HIV-negative before you start taking TRUVADA. Ask your doctor about your risk of getting HIV-1 infection and if TRUVADA for PrEP may be right for you.
visit start.truvada.com
IMPORTANT FACTS (tru-VAH-dah)
This is only a brief summary of important information about taking TRUVADA for PrEP (pre-exposure prophylaxis) to help reduce the risk of getting HIV-1 infection. This does not replace talking to your healthcare provider about your medicine.
MOST IMPORTANT INFORMATION ABOUT TRUVADA FOR PrEP
POSSIBLE SIDE EFFECTS OF TRUVADA FOR PrEP
Before starting TRUVADA for PrEP to help reduce your risk of getting HIV-1 infection: • You must be HIV-1 negative. You must get tested to make sure that you do not already have HIV-1 infection. Do not take TRUVADA for PrEP to reduce the risk of getting HIV-1 unless you are confirmed to be HIV-1 negative. • Many HIV-1 tests can miss HIV-1 infection in a person who has recently become infected. Symptoms of new HIV-1 infection include flu-like symptoms, tiredness, fever, joint or muscle aches, headache, sore throat, vomiting, diarrhea, rash, night sweats, and/or enlarged lymph nodes in the neck or groin. Tell your healthcare provider if you have had a flu-like illness within the last month before starting TRUVADA for PrEP.
TRUVADA can cause serious side effects, including: • Those in the “Most Important Information About TRUVADA for PrEP" section. • New or worse kidney problems, including kidney failure. • Bone problems. • Changes in body fat.
While taking TRUVADA for PrEP to help reduce your risk of getting HIV-1 infection: • You must continue using safer sex practices. Just taking TRUVADA for PrEP may not keep you from getting HIV-1. • You must stay HIV-1 negative to keep taking TRUVADA for PrEP. • Tell your healthcare provider if you have a flu-like illness while taking TRUVADA for PrEP. • If you think you were exposed to HIV-1, tell your healthcare provider right away. • If you do become HIV-1 positive, you need more medicine than TRUVADA alone to treat HIV-1. If you have HIV-1 and take only TRUVADA, your HIV-1 may become harder to treat over time. • See the “How to Further Reduce Your Risk” section for more information. TRUVADA may cause serious side effects, including: • Buildup of lactic acid in your blood (lactic acidosis), which is a serious medical emergency that can lead to death. Call your healthcare provider right away if you have any of these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, nausea, vomiting, stomach-area pain, cold or blue hands and feet, feeling dizzy or lightheaded, and/or fast or abnormal heartbeats. • Severe liver problems, which in some cases can lead to death. Call your healthcare provider right away if you have any of these symptoms: your skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, and/or stomach-area pain. • Worsening of hepatitis B (HBV) infection. If you have HBV and take TRUVADA, your hepatitis may become worse if you stop taking TRUVADA. Do not stop taking TRUVADA without first talking to your healthcare provider, as they will need to check your health regularly for several months. You may be more likely to get lactic acidosis or severe liver problems if you are female, very overweight, or have been taking TRUVADA for a long time.
ABOUT TRUVADA FOR PrEP (PRE-EXPOSURE PROPHYLAXIS) TRUVADA is a prescription medicine used with safer sex practices for PrEP to help reduce the risk of getting HIV-1 infection in adults at high risk: • HIV-1 negative men who have sex with men and who are at high risk of getting infected with HIV-1 through sex. • Male-female sex partners when one partner has HIV-1 infection and the other does not. To help determine your risk, talk openly with your doctor about your sexual health. Do NOT take TRUVADA for PrEP if you: • Already have HIV-1 infection or if you do not know your HIV-1 status. • Take lamivudine (Epivir-HBV) or adefovir (HEPSERA).
TRUVADA, the TRUVADA Logo, TRUVADA FOR PREP, GILEAD, the GILEAD Logo, and HEPSERA are trademarks of Gilead Sciences, Inc., or its related companies. All other marks referenced herein are the property of their respective owners. Version date: April 2016 © 2016 Gilead Sciences, Inc. All rights reserved. TVDC0050 09/16
Common side effects in people taking TRUVADA for PrEP include stomach-area (abdomen) pain, headache, and decreased weight. These are not all the possible side effects of TRUVADA. Tell your healthcare provider right away if you have any new symptoms while taking TRUVADA for PrEP. Your healthcare provider will need to do tests to monitor your health before and during treatment with TRUVADA for PrEP.
BEFORE TAKING TRUVADA FOR PrEP Tell your healthcare provider if you: • Have or have had any kidney, bone, or liver problems, including hepatitis infection. • Have any other medical conditions. • Are pregnant or plan to become pregnant. • Are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed if you become HIV-1 positive because of the risk of passing HIV-1 to your baby. Tell your healthcare provider about all the medicines you take: • Keep a list that includes all prescription and over-the-counter medicines, vitamins, and herbal supplements, and show it to your healthcare provider and pharmacist. • Ask your healthcare provider or pharmacist about medicines that should not be taken with TRUVADA for PrEP.
HOW TO TAKE TRUVADA FOR PrEP • Take 1 tablet once a day, every day, not just when you think you have been exposed to HIV-1. • Do not miss any doses. Missing doses may increase your risk of getting HIV-1 infection. • You must practice safer sex by using condoms and you must stay HIV-1 negative.
HOW TO FURTHER REDUCE YOUR RISK • Know your HIV-1 status and the HIV-1 status of your partners. • Get tested for HIV-1 at least every 3 months or when your healthcare provider tells you. • Get tested for other sexually transmitted infections. Other infections make it easier for HIV-1 to infect you. • Get information and support to help reduce risky sexual behavior. • Have fewer sex partners. • Do not share needles or personal items that can have blood or body fluids on them.
GET MORE INFORMATION • This is only a brief summary of important information about TRUVADA for PrEP to reduce the risk of getting HIV-1 infection. Talk to your healthcare provider or pharmacist to learn more, including how to prevent HIV-1 infection. • Go to start.truvada.com or call 1-800-GILEAD-5 • If you need help paying for your medicine, visit start.truvada.com for program information.
STOPPING THE VIRUS CAN START WITH YOU. Here are two resources that can help.
Watch videos, share information, and see how we can all help stop the virus. HelpStopTheVirus.com YouTube.com/HelpStopTheVirus
Get the answers you need, privately, on your phone. HIVanswers.com/app
© 2016 Gilead Sciences, Inc. All rights reserved. UNBC3359 06/16
JANUARY
FEBRUARY
MARCH
10
7
20
APRIL
10
18
2017 HIV/AIDS AWARENESS DAYS Annual awareness days help to educate the public in general and specific groups in particular about HIV/AIDS. Since the virus affects people from all walks of life, awareness days have increased over the years. Mark these days on your calendar and use the hashtags shown to promote them on social media.
FEBRUARY 7
MARCH 10
MARCH 20
APRIL 10
The Centers for Disease and Control Prevention (CDC) reports that African Americans are the group most affected by HIV/AIDS in the United States. Since 1999, NBHAAD has called on African Americans to set aside the stigma, fear and negative perceptions about HIV testing to find out their status. Socioeconomic issues contribute to high HIV rates in Black communities. According to the CDC, nearly half of HIV diagnoses in 2014 were among African Americans. The goal is to get people educated, involved, tested and treated.
Started by the federal Office on Women’s Health (OWH), this day recognizes the impact of HIV/AIDS on women and girls. Even though HIV diagnoses among women fell 40 percent from 2005 to 2014, women need HIV-related information and more resources for those numbers to continue to drop. According to the CDC, in 2014, women made up 19 percent of new U.S. HIV diagnoses. Females of all ages are encouraged to participate in awareness day walks, read up on needto-know information and be inspired to take action.
This day honoring American Indians, Alaska Natives and Native Hawaiians is observed each year at the start of spring and is intended to empower these groups to get tested and bring HIV/AIDS awareness to their communities. The CDC reports that new HIV diagnoses among American Indians and Alaska Natives are proportional to their population sizes and that new HIV diagnoses among Native Hawaiians have declined. However, there is still much work to be done to lower HIV rates even further in these communities.
To engage those under age 25 on the topic of HIV/AIDS, this awareness day was started in 2013. NYHAAD recognizes that as the first generation never to know a world without HIV, youth are important to ending the epidemic. According to the CDC, about 22 percent of new U.S. HIV diagnoses in 2014 were among 13- to 24-year-olds. For NYHAAD, youth are encouraged to tweet, host events, get tested for HIV and set up tables on school campuses to educate others.
(YOUTH, VIAL, FLOWERS, HANDS, PALM TREES AND GLOBE) ISTOCK (MODELS USED FOR ILLUSTRATIVE PURPOSES)
National Black HIV/AIDS Awareness Day #NBHAAD
National Women and Girls HIV/AIDS Awareness Day #NWGHAAD
National Native HIV/AIDS Awareness Day #NNHAAD
National Youth HIV & AIDS Awareness Day #NYHAAD
MAY
18
19
JUNE
19
5
8
27
APRIL 18
MAY 18
The available—though incomplete—data about transgender people living with HIV/AIDS show that the virus disproportionately affects this community. Headed by The Center for Excellence in Transgender Health, this awareness day inspires transgender and gender nonbinary people to get tested. It focuses on learning about current and future options for prevention and treatment. NTHTD also encourages local testing events and campaigns promoting testing and awareness in the trans community. Use the hashtags #NTHTD and #TransHIV to share your plans.
HVAD recogniz of volunteers, c members, heal and scientists w a safe, effectiv HIV vaccine. HV the progress of the importance being conducte how others can tribute. The goa to one day have AIDS-free gene tion both nation and globally, w with continued preventive and therapeutic vac research, is wit our reach.
JUNE 27
AUGUST 28
Founded by the former National Association of People with AIDS in 1995, NHTD is a call to people of all ages to know the facts about HIV. Getting tested allows people to know their status so they can learn how to stay negative or get treatment if they test positive to help prevent further spreading the virus. According to the CDC, one in eight people with HIV don’t know they have the virus. Every year, up to 45,000 people become HIV positive, which is why NHTD is important. NHTD gives us all a chance to take control of our sexual health.
HIV/AIDS affec faiths across th States. Global groups have ca leaders to capi of their followe power to help e Religion can he living with and HIV/AIDS. This being launched effort to raise a the importance prevention, sup within faith com goal is to bring Christians, Jew Hindus and me religions to figh
National Transgender HIV Testing Day #NTHTD
National HIV Testing Day #NHTD
HIV Vaccine Aw #HVAD
National Faith Awareness Da #NFHAAD
JULY
wareness Day
zes the thousands community lth professionals working to create ve and affordable VAD showcases f the work so far, e of the research ed and n conal is e an eranally which, d d ccine thin
h HIV/AIDS ay
cts all he United health alled on religious italize on the trust ers and use their end the epidemic. elp heal those affected by national day is d this year in an awareness about e of HIV education, pport and love mmunities. The together Muslims, ws, Buddhists, embers of other ht HIV/AIDS.
AUGUST
28
SEPTEMBER
18
27
OCTOBER
NOVEMBER
DECEMBER
15
1
MAY 19
MAY 19
JUNE 5
JUNE 8
The Banyan Tree Project founded this awareness day in 2005. Through education and storytelling, this national social marketing campaign has worked to create environments that are accepting of Asians and Pacific Islanders living with HIV/AIDS. It’s estimated that nearly two thirds of Asians have never been tested for HIV, due in part to stigma. Although the CDC reports that as of 2014, Asians accounted for only 2 percent of new HIV diagnoses and Pacific Islanders for less than 1 percent, new HIV diagnoses among Asians have been increasing.
About 850,000 Americans are living with hepatitis B virus (HBV) and 3.5 million with hepatitis C virus (HCV). This testing day is important to Americans living with HIV/AIDS because many of them also have hepatitis. The CDC reports that one quarter of people with HIV nationwide also have HCV and that people at risk for HIV are also at risk for HBV. The goals of this day are to provide support and resources for those with viral hepatitis, to increase awareness of HCV and HBV and to encourage testing.
This day honors all Americans who identify as long-term survivors of HIV. (June 5, 1981, marks the first official reporting of what would come to be known as the AIDS epidemic.) HLTSAD raises awareness about long-term survivors and makes sure they continue to be included in the ongoing HIV conversation. For those still alive who contracted the virus at the beginning of the epidemic, things have greatly changed. This day reminds them they are still important.
HIV prevalence in the Caribbean is the second highest globally after sub-Saharan Africa. Founded in 2006, NCAHAAD brings HIV awareness to Caribbean Americans and Caribbean-born individuals in the United States through resources, education and testing. NCAHAAD is held annually during National Caribbean American Heritage Month. Local NCAHAAD events nationwide emphasize the importance of learning about prevention, testing and treatment.
SEPTEMBER 18
SEPTEMBER 27
OCTOBER 15
According to the CDC, people age 50 and older accounted for an estimated 17 percent of new U.S. HIV diagnoses in 2014. This age group has the same HIV risk factors as younger people but may be less aware of them. The AIDS Institute first observed NHAAAD in 2008. The AIDS Institute wants people to get involved by hosting free HIV screening events, encouraging HIV testing among older adults and hosting events at senior centers and nursing home facilities.
HIV/AIDS continues to play a major role in the lives of gay and bisexual men. This is why the former National Association of People With AIDS established NGMHAAD. According to the CDC, nearly one in seven gay and bi men living with HIV are unaware they have it. The purpose of this national awareness day is to get individuals tested so that those who are positive can get on treatment, remain healthy and reduce the likelihood of transmitting the virus to their partners.
This awareness day is observed on the last day of Hispanic Heritage Month. While representing only about 17 percent of the U.S. population, Latinos made up almost one quarter of new HIV diagnoses nationwide in 2014, according to the CDC. The Latino Commission on AIDS and the Hispanic Federation spearhead NLAAD. The goal is to get Latinx (pronounced “La-teen-ex” and used as a gender-neutral plural pronoun for Latinos/ Latinas) people to join the fight to end the epidemic.
National Asian & Pacific Islander HIV/AIDS Awareness Day #NAPIHAAD
National HIV/AIDS and Aging Awareness Day #NHAAAD
National Hepatitis Testing Day #NHTD
National Gay Men’s HIV/AIDS Awareness Day #NGMHAAD
HIV Long-Term Survivors Day #HLTSAD
National Latinx AIDS Awareness Day #NLAAD
National Caribbean American HIV/AIDS Awareness Day #NCAHAAD
DECEMBER 1
World AIDS Day #WAD The World Health Organization founded World AIDS Day with support from the United Nations. About 36.7 million people across the globe have HIV, according to UNAIDS. Every December 1, the world comes together to continue the fight against HIV, show support for those living with the virus and to remember those lost to it. Community organizations, health advocates, governments and others coordinate related events worldwide.
A HEALTHIER LIFE CAN START WITH HIV TREATMENT. Starting HIV treatment right after diagnosis can help stop the virus in your body. Because treatment helps lower the damage HIV causes to your immune system. Plus, doctors and scientists have found that it can help lower the risk of heart disease and certain cancers.
TREATMENT ALSO HELPS YOU PROTECT OTHERS. HIV treatment can help lower the amount of virus in your body. It can get so low, it can’t be measured by a test. It’s called being undetectable. And it helps lower the chance of passing HIV on to others by more than 90%.
STOPPING T CAN START
Here are two resour
Watch videos, share see how we can all h
HelpStopThe
TALK TO YOUR HEALTHCARE PROVIDER.
YouTube.com/Hel
Have an open conversation. When you work together it helps your healthcare provider find the treatment that’s right for you.
Get the answe privately, on y
Watch HIV: “Treat 2 Prevent”
HIVanswers
See how staying on treatment can help protect you and the people you care about. YouTube.com/HelpStopTheVirus
© 2016 Gilead Scienc Scien
THE VIRUS WITH YOU.
START HIV TREATMENT. HELP PROTECT YOUR HEALTH.
rces that can help.
e information, and help stop the virus.
eVirus.com
lpStopTheVirus
ers you need, your phone.
There is no cure for HIV, but find out how treatment helps make it possible to live a healthy life.
s.com/app
ces, Inc. All rights reserved. UNBC3359 06/16 nces,
See Inside